IL187168A0
(en )
2008-02-09
Improved nanobodiestm for the treatment of aggregation-mediated disorders
HUS1600048I1
(en )
2017-01-30
Preparation for the treatment of Fabry disease
SMP200900085B
(en )
2010-11-12
3-imidazolyl-indoles for the treatment of malolysiseproliferative.
HUE054495T2
(en )
2021-09-28
Preparation for the treatment of cancer
ZA200706791B
(en )
2012-01-25
Isoxazole combretasin derivatives for the treatment of disorders
ATE434620T1
(en )
2009-07-15
DIHYDROTHIENOPYRIMIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES
IL191832A0
(en )
2008-12-29
Pyridiazinone derivatives for the treatment of tumours
DE602005027052D1
(en )
2011-05-05
ENDOSCOPE TREATMENT SYSTEM
EP1854415A4
(en )
2015-01-21
SURGICAL TREATMENT DEVICE
DK1928438T3
(en )
2013-04-22
Use of ibudilast for the treatment of drug dependence
AP2007004157A0
(en )
2007-10-31
N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain
BRPI0816712A2
(en )
2016-11-08
interval therapy for the treatment of tinnitus
BRPI0815551A2
(en )
2015-02-18
TREATMENT THROUGH HUCBC OF BETA-AMYLOID DISEASE
PL1890684T3
(en )
2014-05-30
Treatment of sleep-wake disorders
DK1863899T3
(en )
2013-10-14
skin treatment
DE602006019395D1
(en )
2011-02-17
MEDIA TREATMENT FACILITY
ATE504297T1
(en )
2011-04-15
VISNADIN FOR THE TREATMENT OF ITCH OF THE SCALP
IL192933A0
(en )
2009-02-11
Benzoisoindole derivatives for the treatment of pain
DE602006003094D1
(en )
2008-11-20
4-PHENYL-5-OXO-1,4,5,6,7,8-HEXAHYDROCHINOLINE DERIVATIVES FOR THE TREATMENT OF BARRENESS
ITRM20050179A1
(en )
2006-10-14
APPLICABLE COMPOSITION FOR THE TREATMENT OF PARADONTAL DISEASES.
FI20051207A0
(en )
2005-11-25
Device for treatment of the back
DE602005016141D1
(en )
2009-10-01
S-MIRTAZAPINE FOR THE TREATMENT OF HITZEWALLUNGEN
IL187792A0
(en )
2008-11-03
4-anilino-3-quinolinecarbonitriles for the treatment of cancer
PL1959957T3
(en )
2012-12-31
Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis
IL190182A0
(en )
2008-11-03
2-aminoalcohols for the treatment of neurodegenerative diseases